Borax & Boron 4 Health
English discussion group for healing with Borax aka Boron
إظهار المزيد📈 نظرة تحليلية على قناة تيليجرام Borax & Boron 4 Health
تُعد قناة Borax & Boron 4 Health (@borax4healing) في القطاع اللغوي الإنكليزية لاعباً نشطاً. يضم المجتمع حالياً 11 200 مشتركاً، محتلاً المرتبة 1 942 في فئة نمط حياة صحي والمرتبة 3 182 في منطقة الولايات المتحدة.
📊 مؤشرات الجمهور والحراك
منذ تأسيسه في невідомо، حقق المشروع نمواً سريعاً وجمع 11 200 مشتركاً.
بحسب آخر البيانات بتاريخ 05 سبتمبر, 2026، تحافظ القناة على نشاط مستقر. خلال آخر 30 يوماً تغيّر عدد الأعضاء بمقدار 374، وفي آخر 24 ساعة بمقدار 2، مع بقاء الوصول العام مرتفعاً.
- حالة التحقق: غير موثّقة
- معدل التفاعل (ER): يبلغ متوسط تفاعل الجمهور 19.70%. وخلال أول 24 ساعة من النشر يحصد المحتوى عادةً 8.35% من ردود الفعل نسبةً إلى إجمالي المشتركين.
- وصول المنشورات: يحصل كل منشور على متوسط 2 205 مشاهدة. وخلال اليوم الأول يجمع عادةً 935 مشاهدة.
- التفاعلات والاستجابة: يتفاعل الجمهور بانتظام؛ متوسط التفاعلات لكل منشور يبلغ 51.
- الاهتمامات الموضوعية: يركز المحتوى على مواضيع رئيسية مثل lithium, silica, calcium, mineral, thyroid.
📝 الوصف وسياسة المحتوى
يصف المؤلف القناة بأنها مساحة للتعبير عن الآراء الذاتية:
“English discussion group for healing with Borax aka Boron”
بفضل وتيرة التحديث المرتفعة (أحدث البيانات بتاريخ 06 سبتمبر, 2026) تحافظ القناة على حداثتها ومستوى وصول مرتفع. وتُظهر التحليلات تفاعلاً نشطاً من الجمهور، ما يجعلها نقطة تأثير مهمة ضمن فئة نمط حياة صحي.
جاري تحميل البيانات...
| التاريخ | نمو المشتركين | الإشارات | القنوات | |
| 06 سبتمبر | +9 | |||
| 05 سبتمبر | +3 | |||
| 04 سبتمبر | +5 | |||
| 03 سبتمبر | +8 | |||
| 02 سبتمبر | +12 | |||
| 01 سبتمبر | +15 |
| 2 | The pregnant woman with iron deficiency anemia for whom lactoferrin produces better hemoglobin restoration than ferrous sulfate at lower doses with fewer side effects is benefiting from the same iron delivery system that has been nourishing infants for millions of years.
The premature infant whose risk of necrotizing enterocolitis and sepsis is reduced by lactoferrin supplementation is being protected by the same protein that would have arrived in breast milk if pregnancy had reached term.
The patient in the Japanese colorectal cancer prevention trial whose polyps did not recur for a year while taking lactoferrin is benefiting from the NK cell activation, iron deprivation of proliferating cells, and direct antiproliferative signaling that lactoferrin has been performing in the immune system since before humans existed as a species.
The older adult in the cognitive impairment trial whose memory assessment scores improved after three months of bovine lactoferrin is experiencing what the premature infant experiences in infectious terms — a reduction in an inflammatory burden that was impairing the function of a system that lactoferrin has been protecting, in one form or another, since the emergence of lactation itself.
Lactoferrin will not replace vaccines, will not replace antibiotics, will not replace iron supplementation for everyone, will not cure cancer.
But it occupies a uniquely sophisticated biological niche — the intersection of iron regulation, antimicrobial defense, immune calibration, gut barrier protection, bone maintenance, and neuroprotection — in which no other single protein operates with comparable breadth.
And the clinical evidence accumulating for iron deficiency in pregnancy, for neonatal infection prevention, for respiratory infection reduction, for colorectal cancer prevention, for gut health, and for emerging cognitive protection is not preliminary enthusiasm for a novel discovery.
It is the accumulating confirmation that a protein whose importance evolution established over millions of years of mammalian development is turning out, in the 21st century, to be exactly as important as the concentration of it in human colostrum always suggested.
The most biologically sophisticated protein in the first food.
Now understood well enough to use deliberately.
For the populations whose biology most needs what lactoferrin has always been designed to provide. 🌿 | 982 |
| 3 | ⚠️ 𝐒𝐀𝐅𝐄𝐓𝐘, 𝐃𝐎𝐒𝐈𝐍𝐆, 𝐀𝐍𝐃 𝐂𝐎𝐍𝐒𝐈𝐃𝐄𝐑𝐀𝐓𝐈𝐎𝐍𝐒
Bovine lactoferrin has an excellent safety profile across clinical trials at doses up to 4.5g daily for up to 12 months. No significant liver, kidney, or blood toxicity signals have been found. It carries GRAS (Generally Recognized as Safe) status in the US as a food ingredient.
𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬:
→ Cow's milk protein allergy: lactoferrin is a bovine milk protein; people with documented cow's milk protein allergy may react to it; start with a very small test dose if milk protein sensitivity is suspected; discuss with an allergist
→ Hemochromatosis or iron overload: lactoferrin can enhance iron absorption; people with hereditary hemochromatosis or other iron overload conditions should not use lactoferrin supplements without medical supervision
→ Immunosuppressed patients: lactoferrin's immune-activating properties could theoretically interact with immunosuppression (post-transplant patients, people on immunosuppressants for autoimmune conditions); discuss with your treating physician before using
→ Pregnancy: specifically studied in pregnancy with an excellent safety record and superior iron delivery compared to standard iron supplements; one of the most pregnancy-appropriate iron support options available; inform your maternity care provider
𝐃𝐨𝐬𝐢𝐧𝐠 𝐛𝐲 𝐢𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧:
→ Iron deficiency anemia (general): 100–300mg bovine lactoferrin daily with meals
→ Iron deficiency in pregnancy: 100mg twice daily — the dose validated in the Paesano trials; continue for at least 30 days and reassess iron markers
→ Infection prevention (respiratory, seasonal): 200–400mg daily during high-risk periods
→ COVID-19 (emerging evidence): 200–600mg daily of standard or liposomal form
→ Colorectal cancer prevention: 2,000–3,000mg daily — the dose used in the Japanese RCT; this is a much higher dose than for infection or iron applications
→ Gut health and microbiome support: 200–400mg daily with meals
→ Bone health: 2,000mg daily — based on the Bharadwaj trial
→ Cognitive support: 250–500mg daily — based on the Mohammed trial
→ Neonatal supplementation: 100mg daily for premature infants — must be under neonatal medical team guidance
💚 𝐓𝐇𝐄 𝐃𝐄𝐄𝐏𝐄𝐑 𝐓𝐑𝐔𝐓𝐇
There is a reason that evolution concentrated lactoferrin in colostrum at 20–30% of total protein — a proportion that no other protein in human milk approaches.
Not antibodies. Not albumin. Not the proteins that provide calories.
Lactoferrin.
At a concentration so high it tells a story about what the newborn immune system most urgently needs in its first days of life — before its own immune responses have developed, before its gut microbiome has established itself, before its iron absorption systems are fully mature.
What a newborn needs in those first days is a single protein that can simultaneously:
Lock up the iron that pathogenic bacteria entering the exposed neonatal gut cannot then access. Directly kill the bacteria, viruses, and fungi the newborn encounters. Calibrate the infant immune system to be vigorous against infection but restrained against the commensal bacteria and food proteins it must tolerate. Provide prebiotic fuel for the beneficial bacteria whose establishment shapes immune health for years. And deliver iron to the infant's own cells through a receptor system that is regulated, efficient, and cannot be hijacked by pathogens.
Nature found one protein that does all of that.
Lactoferrin.
The fact that we had to scientifically discover what it was is a function of the limits of science — for the thousands of years that breastfed infants received billions of molecules of lactoferrin in every feed, nobody knew what was being delivered or why it mattered so profoundly.
Now we know.
And the biological story of lactoferrin has extended far beyond infancy in ways that are still being understood: | 708 |
| 4 | ) gave bovine lactoferrin 250mg daily to 60 patients with mild cognitive impairment and found significant improvements in standard cognitive assessment scores (MoCA and MMSE) alongside improvements in oxidative stress and inflammatory markers compared to placebo at 3 months. This is preliminary — one small trial — but the biological plausibility (neuroinflammation reduction, brain iron regulation, blood-brain barrier crossing) provides strong mechanistic rationale for larger trials.
🌡️ 𝐅𝐎𝐑𝐌𝐒 𝐀𝐍𝐃 𝐁𝐈𝐎𝐀𝐕𝐀𝐈𝐋𝐀𝐁𝐈𝐋𝐈𝐓𝐘 — 𝐖𝐇𝐀𝐓 𝐌𝐀𝐓𝐓𝐄𝐑𝐒 𝐖𝐇𝐄𝐍 𝐂𝐇𝐎𝐎𝐒𝐈𝐍𝐆 𝐀 𝐏𝐑𝐎𝐃𝐔𝐂𝐓
Not all lactoferrin products are equivalent. The form and processing method matter for bioavailability and for which applications the product is best suited:
🔷 Standard bovine lactoferrin: extracted from cow's milk through a cold purification process; the most widely available form; partially broken down by stomach acid and pepsin during digestion (which also generates the active antimicrobial peptide lactoferricin — so some breakdown is not purely a negative); some intact protein is absorbed through the lactoferrin receptor system in the small intestine; generally appropriate for most applications including iron support and infection prevention
🔷 Liposomal lactoferrin: lactoferrin encapsulated in fat vesicles (liposomes) that protect it from stomach acid and digestive enzymes, delivering more intact protein to the intestinal absorption site; used in the Italian COVID-19 trials showing significant benefit; higher cost and less widely available; most appropriate when maximum intact protein delivery is the priority
🔷 Enteric-coated lactoferrin: capsules with a coating that dissolves in the intestine rather than the stomach, bypassing gastric acid; alternative approach to protecting intact protein delivery; less relevant for applications where the lactoferricin generated by gastric pepsin digestion is the active antimicrobial agent
𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐡𝐞𝐧 𝐜𝐡𝐨𝐨𝐬𝐢𝐧𝐠:
→ Look for at least 90% pure lactoferrin — some products contain significant amounts of whey protein alongside a lower percentage of actual lactoferrin
→ Cold-processed products maintain biological activity better than those using high-temperature processing — lactoferrin is heat-sensitive
→ The product should specify bovine lactoferrin (bLF) and ideally indicate processing temperature
→ A glass of cow's milk provides only about 5–30mg of lactoferrin; supplemental doses of 100–3,000mg are required for therapeutic effects — dietary lactoferrin from milk is not a meaningful substitute for supplementation at therapeutic doses | 586 |
| 5 | Multiple randomized controlled trials have examined lactoferrin supplementation for upper respiratory infection prevention and treatment:
→ A 2010 Japanese trial (Yamauchi et al.) of 98 adults during cold and flu season found that lactoferrin supplementation significantly reduced the incidence of fever, cough, and nasal symptoms, and reduced illness duration compared to placebo
→ A 2017 European trial (Mulder et al.) in children found that lactoferrin supplementation significantly reduced the number of days with respiratory infections and reduced school absences
→ A Japanese trial found that lactoferrin supplementation significantly reduced recurrent ear infections (otitis media) in children — consistent with both the antimicrobial and immune-calibrating mechanisms
🔴 𝟒. 𝐂𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥 𝐜𝐚𝐧𝐜𝐞𝐫 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 — 𝐭𝐡𝐞 𝐉𝐚𝐩𝐚𝐧𝐞𝐬𝐞 𝐞𝐯𝐢𝐝𝐞𝐧𝐜𝐞
This is perhaps the most striking single clinical trial finding in lactoferrin research.
A 2014 Japanese randomized controlled trial (Wakabayashi et al., published in Cancer Prevention Research) enrolled 104 patients who had previously had colorectal adenomas (the precancerous polyps that develop into bowel cancer) removed. Half received bovine lactoferrin at 2.9g daily; half received placebo. After 12 months, the researchers assessed how many patients had developed new adenomas.
Results: 8.3% recurrence in the lactoferrin group versus 25.8% in the placebo group — a 68% relative risk reduction in polyp recurrence. This is one of the most dramatic cancer prevention findings for any nutritional intervention in a properly randomized trial.
The multiple mechanisms identified in laboratory studies (iron deprivation of rapidly dividing cells, direct growth inhibition through nucleolin signaling, enhanced NK cell tumor surveillance, inhibition of blood vessel formation to tumors) now have human trial evidence to support them. Replication in larger trials is warranted, and this research area deserves much more attention than it has received.
🔴 𝟓. 𝐆𝐮𝐭 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐠𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐜𝐨𝐧𝐝𝐢𝐭𝐢𝐨𝐧𝐬
𝐇. 𝐩𝐲𝐥𝐨𝐫𝐢 𝐞𝐫𝐚𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧:
Multiple clinical trials from Italy and Iran have found that adding lactoferrin to the standard antibiotic combination treatment for H. pylori (the stomach bacterium causing ulcers and raising stomach cancer risk) improves eradication rates compared to antibiotics alone. Lactoferrin's direct inhibition of H. pylori's ability to attach to the stomach lining adds antimicrobial activity alongside the antibiotic components.
𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐛𝐨𝐰𝐞𝐥 𝐝𝐢𝐬𝐞𝐚𝐬𝐞:
Pilot studies and animal research consistently show that lactoferrin reduces intestinal inflammation in IBD, reduces calprotectin (the standard stool marker of gut inflammation), and helps restore gut barrier function. The combination of anti-inflammatory and antimicrobial effects is particularly relevant for IBD, where both chronic inflammation and gut microbiome disruption drive disease activity.
𝐈𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐛𝐨𝐰𝐞𝐥 𝐬𝐲𝐧𝐝𝐫𝐨𝐦𝐞:
Preliminary evidence suggests symptom improvement and reduced intestinal permeability with lactoferrin supplementation in IBS — with the gut barrier restoration mechanism as the primary proposed pathway.
🔴 𝟔. 𝐁𝐨𝐧𝐞 𝐡𝐞𝐚𝐥𝐭𝐡
A clinical trial by Bharadwaj et al. supplemented 29 postmenopausal women with bovine lactoferrin 2g daily for 3 months and found significant improvements in bone formation markers and significant reduction in bone resorption markers — the biological profile corresponding to improved bone maintenance. Multiple animal studies showing substantial increases in bone mineral density with oral lactoferrin support the mechanistic plausibility. Larger human trials are ongoing.
🔴 𝟕. 𝐂𝐨𝐠𝐧𝐢𝐭𝐢𝐯𝐞 𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧
A 2021 pilot randomized trial (Mohammed et al. | 553 |
| 6 | Standard iron supplements (ferrous sulfate) deliver iron through a single gut transporter (DMT1). This transport system can be blocked by calcium, tea, coffee, phytates, and other common dietary components. It is not regulated by the body's iron need — in states of iron overload, DMT1 iron absorption does not switch off, which is why ferrous sulfate can cause iron overload and why it carries the risk of GI irritation from unabsorbed iron fermenting in the gut.
Lactoferrin delivers iron through a completely different, dedicated receptor system (LRP1 and intelectin-1 receptors on the gut wall). This system is:
→ High-affinity — efficiently capturing iron from lactoferrin for cell uptake
→ Regulated — downregulated when iron stores are adequate, preventing iron overload
→ Not blocked by dietary inhibitors that interfere with ferrous sulfate absorption
→ Not associated with the GI irritation that unabsorbed ferrous iron produces
Additionally, lactoferrin reduces hepcidin — the hormone that the body produces in response to inflammation to block iron absorption and lock iron inside cells. In pregnancy, in chronic illness, and in inflammatory conditions, elevated hepcidin is a primary reason standard iron supplements fail to raise hemoglobin adequately. By reducing hepcidin, lactoferrin improves the overall availability of iron beyond its own direct delivery mechanism.
𝐏𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐢𝐫𝐨𝐧 𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲:
Multiple trials in iron-deficient infants and children confirm that bovine lactoferrin at 100mg daily improves hemoglobin and ferritin with superior tolerability to standard iron supplementation — with the added benefit of simultaneous immune support that is particularly relevant in developing country settings where iron deficiency and high infection burden overlap.
𝐀𝐧𝐞𝐦𝐢𝐚 𝐨𝐟 𝐜𝐡𝐫𝐨𝐧𝐢𝐜 𝐝𝐢𝐬𝐞𝐚𝐬𝐞:
When anemia occurs in the context of chronic inflammatory conditions (inflammatory bowel disease, kidney disease, rheumatoid arthritis), elevated hepcidin blocks iron absorption even when the person is taking iron supplements. Lactoferrin's hepcidin-reducing mechanism is particularly relevant here — addressing the underlying hormonal block rather than simply pushing more iron against a closed door.
🔴 𝟐. 𝐏𝐫𝐞𝐦𝐚𝐭𝐮𝐫𝐞 𝐢𝐧𝐟𝐚𝐧𝐭𝐬 — 𝐭𝐡𝐞 𝐦𝐨𝐬𝐭 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞𝐥𝐲 𝐭𝐫𝐢𝐚𝐥𝐥𝐞𝐝 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
The clinical evidence in premature infants is the most extensively randomized controlled trial-validated application of lactoferrin. Premature infants who cannot receive breast milk are deprived of the massive lactoferrin doses that breast milk would have provided — making supplementation most urgent in this population.
𝐍𝐞𝐜𝐫𝐨𝐭𝐢𝐳𝐢𝐧𝐠 𝐞𝐧𝐭𝐞𝐫𝐨𝐜𝐨𝐥𝐢𝐭𝐢𝐬 (𝐍𝐄𝐂) 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧:
NEC is the most devastating gut emergency of premature infancy — a condition where the immature gut lining is invaded by bacteria, producing catastrophic intestinal inflammation that can cause sections of the gut to die. It carries very high mortality and severe long-term consequences for survivors.
A major Italian trial (Manzoni et al., 2009, published in The Lancet) randomized 472 premature infants to bovine lactoferrin 100mg/day, lactoferrin plus a probiotic, or placebo. The lactoferrin group showed significantly reduced incidence of late-onset blood infections (sepsis) and reduced NEC. Multiple additional Italian trials have confirmed consistent sepsis reduction signals.
A large UK trial (the ELFIN trial, 2019, also published in The Lancet) enrolling over 2,000 premature infants found a less significant primary outcome result — and the evidence remains the subject of active scientific discussion regarding differences in the specific lactoferrin product used. Meta-analyses across multiple trials consistently show significant reductions in NEC and sepsis, and lactoferrin remains part of supplementation protocols in many neonatal intensive care units globally.
🔴 𝟑. 𝐑𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧𝐬 — 𝐜𝐨𝐥𝐝, 𝐟𝐥𝐮, 𝐚𝐧𝐝 𝐛𝐞𝐲𝐨𝐧𝐝 | 547 |
| 7 | Lactoferrin stimulates the cells that build bone (osteoblasts) and simultaneously inhibits the cells that break bone down (osteoclasts). This combination — more bone formation and less bone resorption — is the most favorable biological scenario for maintaining and improving bone density. Multiple animal studies have shown significant increases in bone mineral density with oral lactoferrin supplementation. Human pilot studies have confirmed improvements in bone turnover markers, and larger trials are underway.
🔴 𝟔. 𝐁𝐫𝐚𝐢𝐧 𝐚𝐧𝐝 𝐧𝐞𝐮𝐫𝐨𝐩𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 — 𝐭𝐡𝐞 𝐞𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐟𝐫𝐨𝐧𝐭𝐢𝐞𝐫
Lactoferrin has been found in the brain — in cerebrospinal fluid, in neurons, and in the reactive microglia associated with neurodegenerative disease. It can cross the blood-brain barrier through a specific receptor-mediated transport system (LRP1 receptors on the brain's blood vessel lining allow lactoferrin to be actively transported across into brain tissue).
In the brain, lactoferrin reduces microglial inflammation (the neuroinflammation that drives many neurodegenerative conditions), scavenges the iron that would otherwise participate in the oxidative reactions damaging neurons, and has been shown to reduce the accumulation of amyloid-beta (the protein that aggregates in Alzheimer's disease) in cell culture and animal models. A small but intriguing clinical trial showed significant improvements in cognitive assessment scores in mild cognitive impairment patients taking lactoferrin for three months.
🔴 𝟕. 𝐂𝐚𝐧𝐜𝐞𝐫 𝐛𝐢𝐨𝐥𝐨𝐠𝐲 — 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐚𝐧𝐭𝐢𝐩𝐫𝐨𝐥𝐢𝐟𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐦𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦𝐬
Lactoferrin approaches cancer cell biology from multiple angles simultaneously:
→ Iron deprivation: tumor cells dramatically upregulate their iron acquisition systems because iron is required for rapid DNA replication; lactoferrin sequesters iron, depriving dividing cancer cells of this critical resource
→ Direct growth inhibition: lactoferrin binds to a protein called nucleolin on the surface of many cancer cells, triggering cell cycle arrest — the cancer cell stops dividing
→ Promoting cancer cell death: lactoferrin activates programmed cell death (apoptosis) in multiple cancer cell types
→ Inhibiting new blood vessel formation: tumors require new blood vessels to grow beyond a small size; lactoferrin inhibits VEGF signaling — the primary signal that triggers tumor-supporting angiogenesis
→ Immune surveillance enhancement: lactoferrin's NK cell-activating effect increases the immune system's ability to detect and eliminate cancer cells
The human clinical evidence for this converges in a remarkable colorectal polyp prevention trial, described below.
📊 𝐓𝐇𝐄 𝐂𝐋𝐈𝐍𝐈𝐂𝐀𝐋 𝐄𝐕𝐈𝐃𝐄𝐍𝐂𝐄 — 𝐖𝐇𝐀𝐓 𝐓𝐇𝐄 𝐓𝐑𝐈𝐀𝐋𝐒 𝐒𝐇𝐎𝐖
🔴 𝟏. 𝐈𝐫𝐨𝐧 𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐚𝐧𝐞𝐦𝐢𝐚 — 𝐭𝐡𝐞 𝐦𝐨𝐬𝐭 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥𝐥𝐲 𝐢𝐦𝐩𝐚𝐜𝐭𝐟𝐮𝐥 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
This is where lactoferrin has the most robust and most clinically meaningful human trial evidence — and where the gap between what the evidence supports and what is routinely offered to patients is widest.
In a landmark 2009 randomized controlled trial by Paesano et al., 30 pregnant women with iron deficiency anemia were given either bovine lactoferrin 100mg twice daily or the standard treatment — ferrous sulfate 520mg daily — for 30 days. The lactoferrin group achieved superior hemoglobin improvement (+4.0 g/dL versus +2.9 g/dL) and superior ferritin recovery at a fraction of the iron dose. And the lactoferrin group experienced dramatically fewer side effects — the nausea, constipation, and abdominal pain that cause so many pregnant women to stop taking their prescribed iron supplements.
A larger 2010 trial by the same group — 100 pregnant women — confirmed the finding: better hemoglobin response, better ferritin response, dramatically better tolerability.
𝐖𝐡𝐲 𝐝𝐨𝐞𝐬 𝐥𝐚𝐜𝐭𝐨𝐟𝐞𝐫𝐫𝐢𝐧 𝐝𝐞𝐥𝐢𝐯𝐞𝐫 𝐢𝐫𝐨𝐧 𝐦𝐨𝐫𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐥𝐲 𝐭𝐡𝐚𝐧 𝐟𝐞𝐫𝐫𝐨𝐮𝐬 𝐬𝐮𝐥𝐟𝐚𝐭𝐞 𝐚𝐭 𝐚 𝐥𝐨𝐰𝐞𝐫 𝐝𝐨𝐬𝐞? | 583 |
| 8 | 𝐀𝐠𝐚𝐢𝐧𝐬𝐭 𝐟𝐮𝐧𝐠𝐢: Lactoferrin disrupts the cell walls and membranes of Candida albicans and inhibits the biofilms that Candida forms. Since Candida requires iron to express many of its virulence factors, the iron sequestration adds another layer of antifungal activity.
🔴 𝟑. 𝐈𝐦𝐦𝐮𝐧𝐞 𝐜𝐚𝐥𝐢𝐛𝐫𝐚𝐭𝐢𝐨𝐧 — 𝐧𝐞𝐢𝐭𝐡𝐞𝐫 𝐬𝐢𝐦𝐩𝐥𝐲 𝐬𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐧𝐠 𝐧𝐨𝐫 𝐬𝐮𝐩𝐩𝐫𝐞𝐬𝐬𝐢𝐧𝐠
This is one of lactoferrin's most sophisticated properties — and one that sets it apart from most immune-affecting compounds.
Lactoferrin does not simply activate the immune system, and it does not simply suppress it. It calibrates it — producing different effects depending on what the immune system is currently doing:
When the immune response is insufficient (during active infection): lactoferrin activates macrophages (the large immune cells that engulf pathogens), increases NK cell killing activity (the cells that target virally infected and cancerous cells), primes neutrophils for more effective action, and promotes dendritic cell maturation (which initiates the adaptive immune response). It turns up what needs to be turned up.
When inflammation has become excessive (in sepsis, in chronic inflammatory disease, after the acute infection phase): lactoferrin reduces the production of the pro-inflammatory signaling molecules (cytokines like TNF-alpha, IL-6, and IL-1beta) that would otherwise cause collateral tissue damage. It also promotes the development of regulatory T cells — the immune cells whose job is to prevent the immune system from overreacting. It turns down what needs to be turned down.
This dual action — more immune response when needed, less inflammatory damage when the response is already excessive — is exactly what effective host defense requires, and almost no single natural compound performs it as elegantly as lactoferrin.
Lactoferrin also reduces histamine release from mast cells, giving it a direct anti-allergic effect.
🔴 𝟒. 𝐆𝐮𝐭 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐦𝐞 𝐬𝐮𝐩𝐩𝐨𝐫𝐭
Lactoferrin interacts with the gut in multiple beneficial ways:
It acts as a prebiotic: the sugar chains attached to the lactoferrin protein serve as food for Bifidobacterium species — the beneficial bacteria that dominate the healthy infant gut microbiome and that are strongly associated with immune health and reduced allergy risk. First documented in the infant gut, this prebiotic function may extend to supporting adult microbiome health as well.
It strengthens the gut barrier: lactoferrin stimulates the production of tight junction proteins — the molecular "zippers" that seal the gaps between gut lining cells and prevent unwanted substances from leaking through into the bloodstream. This directly supports gut barrier integrity and reduces intestinal permeability (the "leaky gut" that drives systemic inflammation).
It promotes gut lining cell growth and renewal: lactoferrin stimulates intestinal epithelial cells to proliferate and mature — supporting the constant renewal of the gut lining that is essential for both barrier function and nutrient absorption.
🔴 𝟓. 𝐁𝐨𝐧𝐞 𝐡𝐞𝐚𝐥𝐭𝐡 — 𝐭𝐡𝐞 𝐮𝐧𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲
One of the most surprising findings in lactoferrin research — completely unexpected from its originally described functions — is its direct effect on bone biology. | 628 |
| 9 | 🔴 𝟐. 𝐃𝐢𝐫𝐞𝐜𝐭 𝐚𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐚𝐜𝐭𝐢𝐨𝐧 — 𝐛𝐞𝐲𝐨𝐧𝐝 𝐢𝐫𝐨𝐧 𝐬𝐭𝐚𝐫𝐯𝐚𝐭𝐢𝐨𝐧
Lactoferrin also kills pathogens directly — through mechanisms that work even when iron is abundantly available:
𝐀𝐠𝐚𝐢𝐧𝐬𝐭 𝐛𝐚𝐜𝐭𝐞𝐫𝐢𝐚: The positive charge on lactoferrin's surface attracts it to the negatively charged outer wall of bacteria. It latches on and destabilizes the bacterial membrane — increasing its permeability until the bacterium can no longer maintain its internal environment and dies. This works against a broad range of bacteria: E. coli, Staphylococcus aureus, Pseudomonas, H. pylori, Clostridium difficile, and many others.
There is a particularly interesting twist here: when lactoferrin passes through the stomach and encounters the digestive enzyme pepsin, pepsin cleaves a small peptide from lactoferrin's end called lactoferricin. This peptide is even more potently antimicrobial than the parent protein — it penetrates bacterial membranes and disrupts them from within. This means that gastric acid and pepsin, which might be expected to destroy lactoferrin's benefits, actually generate an additional antimicrobial weapon from it. Taking lactoferrin orally may be more beneficial than it first appears.
Lactoferrin also disrupts bacterial biofilms — the protective enclosures that bacteria build around themselves and which make antibiotic treatment far less effective. | 659 |
| 10 | coli, Staphylococcus, and Candida can access it — while simultaneously delivering that iron to the infant's own gut cells through a dedicated, high-affinity receptor system, ensuring the baby gets the iron it needs without making it available to pathogens. | 660 |
| 11 | 🔬 𝐖𝐇𝐀𝐓 𝐋𝐀𝐂𝐓𝐎𝐅𝐄𝐑𝐑𝐈𝐍 𝐀𝐂𝐓𝐔𝐀𝐋𝐋𝐘 𝐈𝐒
Lactoferrin is a protein belonging to the transferrin family — the group of proteins responsible for binding and transporting iron throughout the body. What makes lactoferrin unique within this family is its extraordinary combination of features.
Each lactoferrin molecule is shaped like two connected lobes, and each lobe can grip one iron atom. So each molecule carries two iron atoms — and holds onto them with remarkable tenacity even in the acidic environments of the stomach and inflamed tissue where most iron-binding proteins would release their iron. This pH stability is one of lactoferrin's most important features, because it means the protein can prevent iron from becoming available to bacteria and cancer cells even in the hostile acidic conditions where those pathogens thrive.
Lactoferrin is also strongly positively charged on its surface. Since most bacterial cell walls, viral surfaces, and pathogen membranes carry a negative charge, lactoferrin is electrostatically attracted to them — setting up the first step of its direct antimicrobial attack.
𝐖𝐡𝐞𝐫𝐞 𝐥𝐚𝐜𝐭𝐨𝐟𝐞𝐫𝐫𝐢𝐧 𝐢𝐬 𝐟𝐨𝐮𝐧𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐛𝐨𝐝𝐲:
→ Human colostrum (first milk): 5–7g per liter — extraordinary, making it one of the most abundant proteins in the first food
→ Mature breast milk: 1–2g per liter — still very high
→ Human tears: 2g per liter — one of the highest concentrations in any body fluid; the eyes face constant microbial challenge and require constant antimicrobial protection
→ Nasal secretions: 0.5–1g per liter — the first line of defense for the respiratory tract
→ Blood during infection: rises dramatically as neutrophils release their stored lactoferrin at infection sites
→ Cow's milk: only 0.02–0.2g per liter — about 50 times less than human breast milk; this difference is why supplemental lactoferrin is so relevant for formula-fed infants
𝐁𝐨𝐯𝐢𝐧𝐞 𝐥𝐚𝐜𝐭𝐨𝐟𝐞𝐫𝐫𝐢𝐧 (𝐟𝐫𝐨𝐦 𝐜𝐨𝐰'𝐬 𝐦𝐢𝐥𝐤):
The lactoferrin used in supplements comes from cow's milk and is called bovine lactoferrin. It shares approximately 70% of the amino acid sequence of human lactoferrin and approximately 60–70% of its biological activities. Bovine lactoferrin is more protease-resistant than human lactoferrin — meaning it survives the stomach's digestive environment better, which actually makes it well-suited for oral supplementation. It has been the subject of the vast majority of clinical trials.
𝐓𝐡𝐞 𝐭𝐰𝐨 𝐬𝐚𝐭𝐮𝐫𝐚𝐭𝐢𝐨𝐧 𝐬𝐭𝐚𝐭𝐞𝐬:
Lactoferrin exists in two forms depending on how much iron it is carrying:
→ Apo-lactoferrin (iron-free): the most antimicrobial form — it actively scavenges iron from the environment, starving bacteria of what they need to survive; the predominant form in human breast milk
→ Holo-lactoferrin (iron-loaded): the form that delivers iron to cells; most relevant to the iron supplementation applications
⚡ 𝐖𝐇𝐀𝐓 𝐋𝐀𝐂𝐓𝐎𝐅𝐄𝐑𝐑𝐈𝐍 𝐀𝐂𝐓𝐔𝐀𝐋𝐋𝐘 𝐃𝐎𝐄𝐒 — 𝐓𝐇𝐄 𝐌𝐄𝐂𝐇𝐀𝐍𝐈𝐒𝐌𝐒
🔴 𝟏. 𝐒𝐭𝐚𝐫𝐯𝐢𝐧𝐠 𝐩𝐚𝐭𝐡𝐨𝐠𝐞𝐧𝐬 𝐨𝐟 𝐢𝐫𝐨𝐧 — 𝐧𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐢𝐦𝐦𝐮𝐧𝐢𝐭𝐲
Iron is a nutrient that virtually every living organism needs — including bacteria, fungi, and cancer cells. The body has evolved a strategy called "nutritional immunity": when infection is detected, the body withholds iron from the local environment, starving pathogens of what they need to grow.
Lactoferrin is a primary weapon in this strategy. When neutrophils (the immune system's first responders) rush to an infection site, they release stored lactoferrin in large quantities. The lactoferrin grabs iron from the surrounding fluid and holds onto it — not releasing it to bacteria, not releasing it to fungi, not releasing it to cancer cells that have upregulated their iron-acquisition machinery to fuel rapid cell division.
In the infant gut, this mechanism protects the newborn from intestinal pathogens. Apo-lactoferrin in breast milk binds iron in the gut before E. | 686 |
| 12 | I recently mentioned that I am taking Lactoferrin to assist with sub-optimal ferritin level. I saw this posted on FB by Pete Wurst today. How timely!
~~~~~~~~~~~~
There is a protein in human breast milk whose concentration in colostrum — the first milk produced in the days after birth — is so extraordinarily high that it makes up approximately 20–30% of total colostrum protein.
Not just any protein. Not the immune antibodies most people know about. Not the calories of fat and carbohydrate. This specific protein — lactoferrin — is present at concentrations suggesting that evolution considered it among the most urgent things to deliver to a newborn in the first days of life.
And lactoferrin is everywhere else in the body too. In tears (one of the highest concentrations found anywhere in the body). In saliva. In nasal secretions. In the mucus lining the airways. In immune cells called neutrophils, which release lactoferrin in enormous quantities wherever infection breaks out. In the seminal fluid. In bile. Virtually every surface where the body meets the outside world contains lactoferrin — and the pattern is not coincidental. It is telling us something about what this protein does.
What lactoferrin does is extraordinary in its breadth:
It locks up iron in a form that bacteria and cancer cells cannot access — starving them of a nutrient they desperately need.
It directly kills bacteria, viruses, fungi, and parasites through mechanisms that do not depend on iron at all.
It calibrates the immune system — turning it up when infection is present, and turning it down when inflammation is becoming excessive and damaging.
It acts as a prebiotic in the infant gut, feeding the beneficial bacteria whose establishment shapes immune development for years.
It strengthens the gut barrier, reduces intestinal permeability, and supports gut health in adults.
And it has clinical trial evidence for applications ranging from iron-deficiency anemia in pregnancy (where it outperforms standard iron supplements at lower doses with fewer side effects) to neonatal infection prevention to colorectal cancer prevention to emerging benefits in cognitive decline.
Most people who are prescribed iron supplements for iron deficiency anemia — and there are an estimated 1.6 billion people globally with this condition — have never been offered lactoferrin as an option. Multiple randomized controlled trials now show it produces equivalent or superior hemoglobin improvement compared to standard ferrous sulfate with dramatically better gut tolerability and with the additional benefit of immune support that iron supplements alone do not provide.
This guide explains why. 🌿 | 868 |
| 13 | لا يوجد نص... | 1 294 |
| 14 | Thyroid hormone increases ferritin, and ferritin falls when thyroid hormone drops
I found this interesting because at one point, my ferritin was only 10 before I started my health journey. Copper protocol at 21 mg copper a day helped me raise it to 39 without iron supplementation but this level is still not optimal. Integrative practitioners suggest that ferritin between 70 and 110 is best. Under 50 can contribute to hair loss which I've experienced quite a bit of in the past. I've recently been experimenting and researching new ways to raise it beyond the copper protocol.
From MASTER METABOLISM:
The relationship between thyroid hormones and serum ferritin is more complicated than most people think.
TPO, the enzyme that synthesizes thyroid hormones, requires iron.
Iron deficiency can lower thyroid hormones because iron is needed to make them.
The problem is that iron deficiency is often diagnosed by low ferritin, an iron storage protein.
What’s often overlooked is thyroid hormones' role in ferritin synthesis.
Thyroid hormone stimulates ferritin synthesis independent of body iron stores.
That means that lower thyroid hormone can lead to lower ferritin.
The research has shown that:
— Ferritin increases in hypothyroid patients with Hashimoto’s when given levothyroxine, the precursor to thyroid hormone.
— In people with normal TSH and normal thyroid hormone levels, one week of 75 mcg thyroid hormone T3 increased ferritin between +20% and +240%.
— In people with thyroid hormone resistance, where cell response to thyroid hormone is low, ferritin only increased from +2% to +15% with high doses of thyroid hormone T3.
— Anti-thyroid medications lower thyroid hormones, and ferritin follows the same downward trajectory.
Thyroid hormone status may affect the uptake of iron in the gut, but that’s not the main driver here.
In human cells and rats, thyroid hormone T3 increases ferritin synthesis by affecting an iron-regulatory protein that essentially acts as a brake on ferritin synthesis. The increase in ferritin is not primarily from increased iron absorption.
Another thing to note is that serum ferritin tells us how much of the ferritin protein is present, not how much iron it holds. Those two can move separately.
Other common iron labs are also likely affected by thyroid hormone status.
Serum iron, hemoglobin, red blood cells, and hematocrit increase more in hypothyroid patients given levothyroxine and iron than in those given the same dose of iron alone.
Transferrin increases when hyperthyroidism is corrected, but I can’t find anything on how hypothyroidism affects it. TIBC rose significantly when correcting hyperthyroidism in humans, but the opposite trend is seen in animal interventions, where TIBC rises with thyroid hormone. TSAT is derived from serum iron and TIBC, so it’s not clean here either.
Reticulocyte haemoglobin ***may*** help separate the two causes of lower ferritin with concurrent lower thyroid hormones. It reads hemoglobin loaded into new red cells, so it reflects recent iron supply rather than any thyroid-driven ferritin synthetic response.
Ref:
THE INFLUENCE OF IRON STATUS ON IODINE UTILIZATION AND THYROID FUNCTION
Serum ferritin as a marker of thyroid hormone action on peripheral tissues
Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element
Relation between thyroid status and ferritin metabolism in rats
Thyroidectomy Increases Rat Hepatic Ferritin Iron
Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: a randomized, double-blind, controlled study
Iron metabolism in patients with Graves’ hyperthyroidism
PLASMA IRON BINDING CAPACITY AND IRON STORES IN ALTERED THYROID METABOLISM IN THE RAT | 1 522 |
| 15 | لا يوجد نص... | 1 643 |
| 16 | Let’s talk about this issue. While I hate that this pesticide has been approved and will be used in the USA, I think we can mitigate the risks with what we know about trifludimoxazin.
Trifludimoxazin is a fluoride based chemical that has been known to cause thyroid cancer in rats. Its seems like they’re finding a new way to put fluoride in us, doesn’t it? Fluoride in drinking water will be removed in the coming years due to litigation and some cities have already removed it proactively.
Thyroid cancer is caused by iodine deficiency. Iodine is depleted/blocked from the body by fluoride and its cousin, bromide.
Boron, copper and iodine all kick fluoride out of the body. If you are taking all of these already then you will be well protected. Of course, eating organic is an excellent way to avoid exposure as well. We can also hope that the lawsuit filed by environmental groups will stop trifludimoxazin from seeing the light of day but for now the only thing in the way of it being used is the ramp up time needed for BASF to start making it and selling it. | 2 126 |
| 17 | I got my 20 mule team here. I bought from the US site twice. It cost me 60 euro for a 4 pound box including taxes and import duty. Worth every cent. Change country at the top of the main page. https://www.desertcart.co.uk/ | 1 296 |
| 18 | For the UK members struggling to find borax 👇 | 1 257 |
| 19 | Last reminder… be aware of scammers like this guy who stole my profile pic and name. I will never post scammy links like this or DM you directly unless you ask me to! | 1 232 |
| 20 | B Vitamin Deficiency Signs for B1, B2, B3, B5, B7 and B12. | 1 307 |
